Savara Inc stock is traded at $4.83, with a volume of 2,216,659. It is up +10.27% in the last 24 hours and up +3.87% over the past month. Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Previous Close:
$4.38
Open:
$4.46
24h Volume:
2,216,659
Relative Volume:
0.90
Market Cap:
$992.37M
Revenue:
-
Net Income/Loss:
-$129.48M
P/E Ratio:
-
EPS:
-$0.5584
Net Cash Flow:
-$106.97M
1W Performance:
+0.21%
1M Performance:
+3.87%
6M Performance:
-8.35%
1Y Performance:
+21.36%
1-Day Range:
$4.41$4.90
1-Week Range:
$4.33$4.91
52-Week Range:
$3.86$7.01
Savara Inc Stock (SVRA) Company Profile
Name
Savara IncSector
HealthcareIndustry
BiotechnologyPhone
51285113796Address
6836 BEE CAVE ROAD, AUSTIN, TX, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS